Delivery Order SPE2DB20D9331-SPE2DB25FL1W8
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19,812.70 by the Defense Logistics Agency (DLA) on September 15, 2025. The delivery order covers the supply of EYLEA HD 8 mg/0.07 mL vials, a prescription pharmaceutical product, with an ultimate completion date of October 6, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,962.54 on June 20, 2025, for the supply of EYLEA HD 8 mg/0.07 ml vials. The award falls under a larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which enables the issuance of delivery orders for a comprehensive range of pharmaceutical products...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $23,775.24 on September 18, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of EYLEA HD 8 mg/0.07 ml vials. The contract, which is not designated as a set-aside award, is expected to be completed by October 9, 2025, with performance taking place at the awardee's Park Ridge location. This delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of EYLEA 2 mg/0.05 ml vials totaling $25,135.40. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The award carries...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $9,906.30 by the Defense Logistics Agency (DLA) for the supply of EYLEA HD 8 mg/0.07 ml vials. The contract, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,283.85 by the Defense Logistics Agency on August 29, 2025, for the supply of EYLEA 2 mg/0.05 ml vials. The contract utilizes firm fixed-price pricing with an ultimate completion date of September 22, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 for EYLEA HD 8 mg/0.07 ml vials on September 3, 2025. The contract, which carries no set-aside designation, calls for delivery by September 24, 2025, and is funded through the Defense Logistics Agency's Medical Supply Chain program. This delivery order represents a single purchase of a specialized pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,770.31 by the Defense Logistics Agency for the supply of EYLEA 2 mg/0.05 mL vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of May 12, 2025. This award carries no set-aside designation, allowing the vendor to compete on a competitive basis leveraging its woman-owned small...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $36.7K on September 22, 2025, by the Defense Logistics Agency's Medical Supply Chain for EYLEA 2 mg/0.05 mL syringes. This firm fixed-price delivery order is scheduled for completion by October 14, 2025, with performance taking place at the contractor's Park Ridge facility. The award carries no set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $29.3K on September 15, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract, which carries a firm fixed-price structure with no set-aside designation, is for the supply of Eylea 2 mg/0.05 ml syringes and is scheduled for completion by October 6, 2025. This delivery order falls under DMS Pharmaceutical Group's...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1W8Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for EYLEA HD 8 MG/0.07 ML vials with a ceiling value of $39,625.20. This firm fixed-price delivery order, awarded on September 3, 2025, represents a single supply requisition under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The contract carries no set-aside designation, allowing the company to compete on its merits as a woman-owned small business within the federal pharmaceutical procurement marketplace. Performance is scheduled for completion by September 24, 2025, at the company's Park Ridge, Illinois facility. EYLEA HD is a prescription pharmaceutical product used in ophthalmologic treatment, and this delivery order supports the medical supply needs of Department of Defense healthcare facilities. The award reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, with a demonstrated portfolio of delivery orders covering an extensive range of branded and generic prescription drugs, biologics, and specialty medical products to military health facilities nationwide. The DLA's SPE2DB program vehicle enables efficient procurement of pharmaceutical inventory to support military medical operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.6k | 9/3/25 |